ISRCTN ISRCTN71826974
DOI https://doi.org/10.1186/ISRCTN71826974
Protocol serial number RADIATION
Sponsor British National Lymphoma Investigation (BNLI) (UK)
Funder British National Lymphoma Investigation (UK)
Submission date
19/08/2002
Registration date
19/08/2002
Last edited
18/10/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr - -
Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleBNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma (NHL)
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedLymphoma (non-Hodgkin's)
InterventionStandard radiotherapy versus low dose radiotherapy
Intervention typeOther
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration1000
Key inclusion criteria1. Any patient receiving local radiotherapy (RT) where the aim of the treatment is local control of that lymphoma, whether as radical treatment of Stage I disease, consolidation therapy after chemotherapy or palliation
2. Histological diagnosis of NHL
3. Aged 18 years or over
4. Able to give informed consent
Key exclusion criteriaNot provided at time of registration
Date of first enrolment30/04/1997
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Plain English results No Yes

Editorial Notes

18/10/2018: Cancer Research UK lay results summary link added to Results (plain English)
11/01/2016: no publications found on PubMed.